Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn’s disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of Medicine (NEJM).
The University of California, San Diego is ranked the 14th best university in the world, up from 15th place last year, and its life sciences and engineering programs are ranked 7th and 13th respectively, according to the 2013 Academic Ranking of World Universities (ARWU).
MIT Technology Review has named Liangfang Zhang, a professor of nanoengineering at the University of California, San Diego, among the top 35 young innovators of 2013. For over a decade, the global media company has recognized a list of exceptionally talented technologists whose work has great potential to transform the world.
UC San Diego faculty members have garnered three of 15 Multidisciplinary University Research Initiative awards granted by the Department of Defense this year. The MURI program supports research by teams of investigators that encompass several traditional science and engineering disciplines to accelerate research progress.
The San Diego Supercomputer Center (SDSC) at the University of California, San Diego, along with small business partners SD Technology and Chickasaw Nation Industries, have brought together their extensive portfolio of information technology services for healthcare and government under the ‘Sherlock’ brand in an effort to serve federal, state, and local governments as well as universities nationwide.
Surgeons at the University of California, San Diego School of Medicine are evaluating a new, combined surgery technique to remove cancerous tumors from the rectum. The hybrid technique uses the body’s natural opening to remove malignancies and diseased tissue while also performing reconstruction.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
